MarkNtel Advisors recently published a research report highlighting that the Global Digital Pathology Market size was valued at around USD 2.1 billion in 2023 and is projected to grow at a CAGR of about 8.5% during the forecast period, i.e., 2024-30. The major factor fueling the growth of the Digital Pathology Market includes the adoption of the digital pathology technique in the medical sector to diagnose illnesses & diseases accurately and in medical schools for teaching purposes.
Moreover, the escalating requirement for digital pathology techniques owing to the growing prevalence of communicable as well as non-communicable diseases coupled with detrimental lifestyles, widespread use of tobacco, and the expansion of population is likely to push the demand for digital pathology even higher in the coming years. Additionally, the digital pathology method offers an accurate & quick diagnosis of diseases resulting in its wide-ranging adoption. Hence, all these factors are highly significant and the major causes leading to the development of the Global Digital Pathology Market.
Analyzing the Global Digital Pathology Market Segmentation
- By Component (Software, Service, and Hardware (Digital Camera Scanner, Communication System, Storage System, and Others (Information Management Systems, Robotic Microscopes, Other Diagnostic Devices, etc.))
- By Application (Clinical Pathology, Teleconsultation, Molecular Diagnostic, Basic & Applied Research, Drug Development, and Others (Training & Education, etc.))
- By Technology (Whole Slide Imaging, Image Analysis Software, Storage, Communication Data, and Others)
- By Type (Genetic Pathology, Hematology & Clinical Pathology, Immunopathology, Chemical Pathology, Forensic Pathology, and Microbiology)
- By End User (Biotech & Pharma Company, Hospitals, Diagnostic Centers, and Others (Academic & Research Institutes))
- By Region (North America, South America, Europe, The Middle East & Africa, and Asia-Pacific)
The highest demand for digital pathology arose from hospitals given the prevalence of diseases, especially non-communicable diseases which has propelled the requirement and necessity to upgrade the diagnostic skills, thus offering accurate & quick diagnostics. Moreover, the cost-efficiency and the accessibility of digital pathology technology to an extensive range of hospitals have resulted in the growth of the Global Digital Pathology Market.
The Global Digital Pathology Market is likely to be dominated by North America during the forecast period owing to the huge amount of investments made in the medical and healthcare industry across the countries like the US, Canada, and Mexico. Some of the major factors leading to the dominance of North America in the given market include the easy accessibility to pathology products & the existence of several major companies in the region. Moreover, the prevalence of cancer has propelled the demand for high-quality diagnostics in the region further boosting the Global Digital Pathology Market.
Companies Holding a Significant Market Share in the Global Digital Pathology Market
The major companies holding a substantial share in the Global Digital Pathology Market are 3Dhistech Ltd., Apollo Enterprise Imaging Corp, Aurora Interactive Ltd., Koninklijke Philips, Corista Llc, Glencoe Software, Inc., Definiens Ag, F. Hoffmann-La Roche Ltd., Digipath Inc., Huron Technologies International Inc., Indica Labs Inc., Leica Biosystem Inc., Omnyx Llc, Ligolab Llc, Mikroscan Technologies Inc., and others.
Comments